info@heorvaluehub.com

HEOR - Value Hub
HEOR - Value Hub

Resources

Throughout their careers, HEOR ValueHub members have authored and contributed to the production of peer-reviewed scientific articles

Useful external links to Health Economics, Pricing and Reimbursement resources

Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers

RE Michels, CH Arteaga, ML Peters, E Kapiteijn, CML Van Herpen, M Krol

External link
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons

N. Akkoç, CH Arteaga, SE Auteri, M Betts, K Fahrbach, M Kim, S Kiri, B Neupane, K Gaffney, PJ Mease

External link
Budget Impact Analysis of a Reduced Maintenance Dose of Certolizumab Pegol in Patients with Axial Spondyloarthritis in the United Kingdom

S. Kiri, CH. Arteaga Duarte, N. Lyris, M. Lamotte, L. Gerlier. J Value in Health. Vol 23, Suppl. 2, S412-S413, Dec. 2020

External link
Cost-Effectiveness Analysis of Certolizumab Pegol Versus Secukinumab and Ixekizumab in Non-Radiographic Axial Spondyloarthritis in the U.S.

Kiri S, Arteaga CH, Lee E, Low R, Tsakeu E, Lamotte M, Gerlier L. AMCP-NEXUS Oct. 2020

External link
The clinical and economic impact of three-monthly long-acting formulation of paliperidone palmitate versus the one-monthly formulation in the treatment of schizophrenia in France: A cost-utility study

Arteaga Duarte CH, Fakra E, Van Gils C et al. L'Encéphale J Clin Psychiatry and Psychopharmacology, December 2019.

External link
Setting Evidence-Based Priorities for Universal Health Coverage – Where is the Evidence?

Downey LE, Rao NV, Selvaraju KV, De Francesco M et al. Technical session presentation at 7th Annual Conference of Indian Health Economics and Policy Association, January 2018

Core obesity model to assess the cost-effectiveness of weight management interventions

De Francesco M, Lopes S, Meincke HH, Vega G, Lean M, Lamotte M. Value in Health 2018; 21: S454. Poster presenation at ISPOR Europe 2018.

External link
Assessing the cost-effectiveness of three-monthly paliperidone palmitate versus its prior monthly formulation for the management of schizophrenia in the UK setting

Arteaga C, Nilforooshan R, Lee J et al. Value in Health 2018 Poster presentation at ISPOR USA 2018

External link
Cost-effectiveness of cladribine tablets for treatment of rrms in the Netherlands

De Francesco M, Mahajan K, Michels R et al. Value in Health 2018; 21: S339–S340. Poster presentation at ISPOR Europe 2018

External link
Hospital economic burden of HIV and its complications in Belgium

Arteaga CH, Chevalier P. Belgian Research AIDS & HIV Consortium BREACH, 2016, 11 Poster presentation at BREACH symposium 2016

External link
Assessing the cost effectiveness of paliperidone palmitate 3-monthly (Trevicta) in the management of schizophrenia in France

Arteaga CH, Guillon P, Fakra E et al. Poster presentation at ISPOR Europe 2016

External link
Cost effectiveness of allogenic pancreatic islet transplantation versus whole pancreas transplantation in the United Kingdom.

De Francesco M, Johnson P, Lamotte M. Value in Health 2016; 19(3): A204. Podium presentation at American Diabetes Association's 76th Scientific Sessions and poster presentation at ISPOR USA 2016

External link
Economic Evaluation of Ipilimumab in First Line Treatment of Advanced Melanoma in Italy

De Francesco M, Lamotte M, Di Rienzo P et al. GRHTA 2016; 3(2): 67 – 79. Scientific article

External link
Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain

De Francesco M, Ronco C, Wacinski PJ et al. J Med Econ. 2016 Feb;19(2):158-68 Scientific article

External link
Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting

Jugrin AV, Hösel V, Ustyugova A, De Francesco M et al. J Med Econ. 2016 Jan;19(1):1-10 Scientific article

External link
Economic evaluation of intravenous iodinated contrast media in Italy

Iannazzo S, Vandekerckhove S, De Francesco M et al. Int J Technol Assess Health Care. 2014 Jan;30(1):69-77 Scientific article

External link
Impatto sul budget di un trattamento personalizzato dell’epatite B cronica HBeAg-negativa in Italia mediante peg-interferone alfa-2a associato alla stopping-rule alla 12a settimana

Iannazzo S, De Francesco M, Coco B et al. PharmacoEconomics Italian Research Articles. 2013, 15(3):123-130 Scientific article

External link
A review of cost-effectiveness evaluations as part of national health technology assessments of biologic DMARDs in the treatment of rheumatoid arthritis

Iannazzo S, De Francesco M, Gomez-Ulloa D et al. Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):455-68. Scientific article

External link
HEOR Logo

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement (updated 5/20/19) and Privacy Policy and Cookie Statement (updated 5/20/19). The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission by HEOR VALUE HUB.

© 2020. All rights reserved. HEOR ValueHub is a trademark of MDF Consulting BVBA and MED-I-MART BVBA